PGRMC1 and ovarian carcinoma: Researchers have demonstrated that hyperoside can induce apoptosis in ovarian cancer cell lines HO-8910 and SKOV3 through the progesterone receptor membrane component 1 (PGRMC1)-dependent autophagy pathway, while also enhancing the cells’ sensitivity to the chemotherapy drug cisplatin.